Home/Merck KGaA/Belén Garijo
BG

Belén Garijo

Chair of the Executive Board and CEO

Merck KGaA

Roles

Chair of the Executive Board and CEOatMerck KGaA
Chair of the Executive Board and CEO of Merck KGaA (Parent Company)atEMD Serono

Merck KGaA Pipeline

DrugIndicationPhase
Bavencio (avelumab) + Axitinib1st-line Renal Cell CarcinomaApproved
Bavencio (avelumab)Maintenance Urothelial CarcinomaApproved
EvobrutinibRelapsing Multiple SclerosisPhase 3
XevinapantLocally Advanced Head and Neck Squamous Cell CarcinomaPhase 3
M9140Colorectal CancerPhase 1/2
M1231NSCLC, Esophageal Squamous Cell CarcinomaPhase 1
M8891Advanced Solid TumorsPhase 1/2